Cargando…

A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts”

Detalles Bibliográficos
Autores principales: Liu, Zhi-Peng, Dai, Hai-Su, Zhang, Yan-Qi, Yin, Xian-Yu, Chen, Zhi-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389302/
https://www.ncbi.nlm.nih.gov/pubmed/36799779
http://dx.doi.org/10.1097/JS9.0000000000000078
_version_ 1785082268405989376
author Liu, Zhi-Peng
Dai, Hai-Su
Zhang, Yan-Qi
Yin, Xian-Yu
Chen, Zhi-Yu
author_facet Liu, Zhi-Peng
Dai, Hai-Su
Zhang, Yan-Qi
Yin, Xian-Yu
Chen, Zhi-Yu
author_sort Liu, Zhi-Peng
collection PubMed
description
format Online
Article
Text
id pubmed-10389302
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103893022023-08-01 A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts” Liu, Zhi-Peng Dai, Hai-Su Zhang, Yan-Qi Yin, Xian-Yu Chen, Zhi-Yu Int J Surg Editorials Lippincott Williams & Wilkins 2023-01-12 /pmc/articles/PMC10389302/ /pubmed/36799779 http://dx.doi.org/10.1097/JS9.0000000000000078 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Editorials
Liu, Zhi-Peng
Dai, Hai-Su
Zhang, Yan-Qi
Yin, Xian-Yu
Chen, Zhi-Yu
A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts”
title A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts”
title_full A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts”
title_fullStr A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts”
title_full_unstemmed A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts”
title_short A commentary on “An artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts”
title_sort commentary on “an artificial intelligence model to predict survival and chemotherapy benefits for gastric cancer patients after gastrectomy development and validation in international multicenter cohorts”
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389302/
https://www.ncbi.nlm.nih.gov/pubmed/36799779
http://dx.doi.org/10.1097/JS9.0000000000000078
work_keys_str_mv AT liuzhipeng acommentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts
AT daihaisu acommentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts
AT zhangyanqi acommentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts
AT yinxianyu acommentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts
AT chenzhiyu acommentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts
AT liuzhipeng commentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts
AT daihaisu commentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts
AT zhangyanqi commentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts
AT yinxianyu commentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts
AT chenzhiyu commentaryonanartificialintelligencemodeltopredictsurvivalandchemotherapybenefitsforgastriccancerpatientsaftergastrectomydevelopmentandvalidationininternationalmulticentercohorts